Catalent_Cell Gene Therapy-01 (002)

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years’ industry experience, Catalent has the proven expertise, superior technologies and flexible solutions at the right scale to help ensure successful product development, launch, tech transfer and reliable clinical and commercial supply. Our team of +13,500, at +40 sites, helps launch in excess of 200 products every year. We supply more than 73 billion doses of +7,000 products for more than 1,000 customers – or 1 in 20 doses taken by patients globally. We partner with 87 of the top 100 global pharmaceutical marketers, 24 of 25 biological marketers, 21 of 25 leading consumer health marketers, and thousands of small innovators globally. At Catalent, we combine deep expertise in the science of drug development and manufacturing with the art of crafting better treatments to deliver successful medicines for our customers and their patients faster.

Catalent, where science meets art.

More products better treatments reliably supplied ™

www.catalent.com